Glaucoma: Goals and Treatment Options CME

Author Information and Disclosures

Release Date: February 29, 2008; Valid for credit through March 1, 2009

Credits Available
Physicians - maximum of 0.5 AMA PRA Category 1 Credit(s)™ for physicians

To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.

Contents of This CME Activity

Downloadable Slides
Glaucoma: Goals and Treatment Options
Powerpoint presentation by L. Jay Katz, MD; Michael Motolko, MD

Legal Disclaimer

The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

Copyright © 2008 Medscape.
Allergan Glaucoma
Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Discuss the importance of early detection and treatment for glaucoma
  2. Detail the available medical therapy options for lowering IOP
  3. Explore the optimal strategies for implementing IOP-lowering therapy
  4. Evaluate adjunctive or replacement approaches to IOP-lowering therapy if first-line treatment fails
Authors and Disclosures

L. Jay Katz, MD
Disclosure: L. Jay Katz, MD, has disclosed that he has received grants for clinical research from Alcon, Allergan, Merck, Pfizer, Ista, and Lumenis. Dr. Katz has also disclosed that he has served on the speakers program for Alcon, Allergan, Merck, Pfizer, Ista, and Lumenis.


Michael A. Motolko, MD, FRCSC, FACS
Disclosure: Michael A. Motolko, MD, FRCSC, FACS, has disclosed that he has received grants for educational activities from Allergan and Alcon. Dr. Motolko has also disclosed that he has served as an advisor or consultant to Allergan and Alcon.


Charlotte Warren
Disclosure: Charlotte Warren has disclosed no relevant financial relationships.
 
Medscape
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Medscape, LLC designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.